Beta amiloide
Beta amyloid inhibitors are compounds that specifically target and inhibit the formation or aggregation of beta-amyloid peptides, which are critically involved in the pathogenesis of Alzheimer's disease. The accumulation of beta-amyloid plaques in the brain is one of the key pathological features of Alzheimer's, contributing to neuronal dysfunction, synaptic loss, and cognitive decline. By preventing the aggregation of beta-amyloid, these inhibitors are being actively researched as potential therapeutic agents aimed at slowing down or even halting the progression of Alzheimer's disease. At CymitQuimica, we offer a variety of high-quality beta-amyloid inhibitors to support your research in neurodegenerative disorders, protein aggregation, and the development of Alzheimer's therapies.
Se han encontrado 246 productos para "Beta amiloide".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
LPYFD-NH2
CAS:neuroprotective peptide that binds to amyloid beta (Aβ)Fórmula:C33H44N6O8Pureza:98%Forma y color:SolidPeso molecular:652.74β-Amyloid (22-35)
CAS:β-Amyloid (22-35) is a 14-aa peptide, shows aggregates and induces neurotoxicity in the hippocampal cells.Fórmula:C59H102N16O21SPureza:98%Forma y color:SolidPeso molecular:1403.62GSK-3β inhibitor 27
GSK-3β inhibitor27 (Compound 1c) is a reversible, competitive inhibitor of GSK-3β with an IC50 value of 2.2 μM. It inhibits tau hyperphosphorylation and reduces Aβ protein aggregation, demonstrating metal chelation and neuroprotective potential. GSK-3β inhibitor27 is promising for research into neurodegenerative diseases, such as Alzheimer's disease.Fórmula:C16H17ClN4O2Forma y color:SolidPeso molecular:332.79SAR228810
SAR228810 is a humanized IgG4 monoclonal antibody inhibitor targeting amyloid beta (Aβ), with a dissociation constant (KD) of 0.43 nM for fibrillar Aβ, which is higher than for monomeric Aβ. It significantly hinders brain amyloid plaque formation, oligomer-induced synaptic dysfunction, and neuronal loss. Furthermore, SAR228810 offers substantial protection against Aβ-mediated neurotoxicity. MINT1526A is applicable in Alzheimer's disease imaging and immunotherapy research.Forma y color:Odour Liquidβ-Amyloid (12-28) (TFA)
β-Amyloid (12-28) (TFA), a peptide fragment of the β-amyloid protein (β1-42)—a 42 amino acid protein primarily found in senile plaque cores—exhibits aggregationFórmula:C91H136N25F3O27Forma y color:SolidPeso molecular:2069.2β-Amyloid (13-27)
CAS:β-Amyloid (13-27) is a peptide consisting of amino acid of 13 to 27 of beta amyloid protein.Fórmula:C84H126N24O24Pureza:98%Forma y color:SolidPeso molecular:1856.05β-Amyloid (1-16)
CAS:β-Amyloid (1-16) is an amyloidogenic protein fragment with a sequence derived from β-amyloid.Fórmula:C84H119N27O28Pureza:98%Forma y color:SolidPeso molecular:1955.04Biotin-β-Amyloid (17-40)
Biotin-β-Amyloid (17-40) is a biotinylated amyloid-ß-(1-40) peptide with a label at the N-terminal, constituting a 24-residue fragment resulting from the post-Fórmula:C120H192N28O33S2Forma y color:SolidPeso molecular:2619.2Nivegacetor
CAS:Nivegacetor(RG6289) is a selective and orally administrable γ-secretase regulator that can affect the production of amyloid-β in cerebrospinal fluid.Fórmula:C23H25F2N7O2Pureza:99.84%Forma y color:Yellow SolidPeso molecular:469.49Chemerin-9 (149-157) TFA
Chemerin-9 (149-157) TFA is a peptide located at positions 149-157 of chemerin-9, acting as a ChemR23/CMKLR1 agonist.Fórmula:C56H67F3N10O15Pureza:99.77%Forma y color:White SolidPeso molecular:1177.18β-Amyloid Protein Precursor 770 (135-155)
CAS:Beta-Amyloid Protein Precursor 770 (135-155)Aβ Protein Precursor 770 (135-155)Fórmula:C116H172N35O31S2Pureza:98%Forma y color:SolidPeso molecular:2617.96Amyloid β-Protein (1-46)
CAS:Amyloid β-Protein (1-46) is a segment of the Aβ peptide.Fórmula:C223H347N59O65SForma y color:SolidPeso molecular:4923.53817β-Amyloid (4-10)
CAS:Antibodies corresponding to beta-amyloid (4-10) are effective in vivo inhibitors of cytotoxicity, amyloid plaque formation and special memory disturbances inFórmula:C39H52N12O12Pureza:98%Forma y color:SolidPeso molecular:880.9β Amyloid(28-35) human
CAS:β-Amyloid(28-35) human is a neurotoxic β-amyloid peptide fragment that contributes to Alzheimer's disease pathogenesis by interacting with neuronal membranes,Fórmula:C36H67N9O9SForma y color:SolidPeso molecular:802.04β-Amyloid (12-28)
CAS:Amyloid β-peptide fragment; minimum section required to bind to brain proteins.Fórmula:C89H135N25O25Pureza:98%Forma y color:SolidPeso molecular:1955.18RAGE antagonist peptide
CAS:RAGE antagonist blocks S100P/A4, HMGB-1; hinders glioma growth, metastasis; reduces PDAC cell growth, NF-κB activity; counters TDI effects in mice.Fórmula:C57H101N13O17SPureza:98%Forma y color:SolidPeso molecular:1272.56APP669-711
APP669-711 is a peptide fragment comprising amino acids 669 to 711 of the amyloid precursor protein (APP). This peptide serves as a biomarker in Alzheimer's disease (AD) research and is useful for diagnosing amyloid deposition in the brain.Fórmula:C210H325N57O61S2Peso molecular:4685.35229β-Amyloid (1-28)
CAS:β-Amyloid (1-28) is a β-Amyloid protein fragment involved in metal binding.Fórmula:C145H209N41O46Pureza:98%Forma y color:SolidPeso molecular:3262.51(Pyr3)-Amyloid β-Protein (3-42)
CAS:(Pyr3)-Amyloid β-Protein (3-42) is the predominant amyloid β peptide structure found deposited in the brains of individuals with Alzheimer's disease and Down syndrome. It is thought that (Pyr3)-Amyloid β-Protein (3-42) accumulates in the brain, leading to the formation of insoluble amyloid β-peptide deposits.Fórmula:C196H299N53O55SForma y color:SolidPeso molecular:4307.19498γ-Secretase Modulators
CAS:gamma-Secretase Modulators serves as a useful treatment for Alzheimer's disease by inhibiting the production of Amyloid-β.Fórmula:C26H24F3N3O3Pureza:98%Forma y color:SolidPeso molecular:483.48
